FDA approves Aurobindo's OTC cetirizine liquid
This article was originally published in The Tan Sheet
Executive Summary
The agency approves Aurobindo Pharma Limited's cetirizine hydrochloride solution, which the Hyderabad, India-based firm plans to launch "shortly." The product is the generic equivalent of McNeil Consumer Healthcare's Children's Zyrtec Allergy and Children's Zyrtec Hives Relief, both oral solutions containing cetirizine HCl and packaged in 1 mg/mL bottles. It will join the growing number of products in the category, which for the 52 weeks ended Jan. 24 had sales of $630.9 million, according to data from Information Resources, Inc. a Chicago-based market research firm. Private-label products in the category sold $149.3 million in the same period, while Johnson & Johnson/McNeil's liquid and powder Zyrtec products sold $26.4 million and Schering-Plough's Claritin liquid/powder products sold $12.7 million